Chipcare is a Toronto-based pre-revenue company developing a highly versatile point-of-care (POC) diagnostics platform which will enable an unparalleled sample-to-action workflow in the clinic. Our Polyvalent Analyzer (PAX) utilizes a patented approach to analyte detection that can perform multiple key assay classes including cell surface markers, proteins, and nucleic acids. From single drops of blood or urine samples, health workers in doctors’ offices, clinics, and remote health locations will be able to rapidly and accurately perform lab quality tests to diagnose or monitor a range of infectious diseases. Chipcare’s patented detection method mimics and miniaturizes flow cytometer and bead array diagnostics methods into a POC platform that can leverage off-the-shelf chemistries for rapid assay menu expansion. Chipcare's initial focus is on the sexually transmitted infections (STI) market in North America and Europe, enabling physicians to provide true test and treat options.
Something looks off?